These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Idiopathic inflammatory myopathies: a review. Ashton C; Paramalingam S; Stevenson B; Brusch A; Needham M Intern Med J; 2021 Jun; 51(6):845-852. PubMed ID: 34155760 [TBL] [Abstract][Full Text] [Related]
64. Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies. Parkes JE; Rothwell S; Day PJ; McHugh NJ; Betteridge ZE; Cooper RG; Ollier WE; Chinoy H; Lamb JA; Arthritis Res Ther; 2016 Jul; 18(1):156. PubMed ID: 27388770 [TBL] [Abstract][Full Text] [Related]
65. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets. Haq SA; Tournadre A Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431 [TBL] [Abstract][Full Text] [Related]
68. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis. Mandel DE; Malemud CJ; Askari AD Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083 [TBL] [Abstract][Full Text] [Related]
69. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Mastaglia FL; Phillips BA Rheum Dis Clin North Am; 2002 Nov; 28(4):723-41. PubMed ID: 12510664 [TBL] [Abstract][Full Text] [Related]
72. Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey. Yoshida A; Kim M; Kuwana M; Ravichandran N; Makol A; Sen P; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita T; Salim B; Velikova T; Edgar Gracia-Ramos A; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Rheumatology (Oxford); 2023 Mar; 62(3):1204-1215. PubMed ID: 35920795 [TBL] [Abstract][Full Text] [Related]
73. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies]. Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158 [TBL] [Abstract][Full Text] [Related]
74. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. Shamim EA; Rider LG; Pandey JP; O'Hanlon TP; Jara LJ; Samayoa EA; Burgos-Vargas R; Vazquez-Mellado J; Alcocer-Varela J; Salazar-Paramo M; Kutzbach AG; Malley JD; Targoff IN; Garcia-De la Torre I; Miller FW Arthritis Rheum; 2002 Jul; 46(7):1885-93. PubMed ID: 12124873 [TBL] [Abstract][Full Text] [Related]
75. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires. Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700 [TBL] [Abstract][Full Text] [Related]
76. Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity. Watanabe E; Kato K; Gono T; Chiba E; Terai C; Kotake S Rheumatology (Oxford); 2021 Jan; 60(1):322-332. PubMed ID: 32770187 [TBL] [Abstract][Full Text] [Related]
77. Risk factors and disease mechanisms in myositis. Miller FW; Lamb JA; Schmidt J; Nagaraju K Nat Rev Rheumatol; 2018 Apr; 14(5):255-268. PubMed ID: 29674613 [TBL] [Abstract][Full Text] [Related]
78. Inflammatory myopathies: an update for neurologists. Silva AMS; Campos ED; Zanoteli E Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):238-248. PubMed ID: 35976321 [TBL] [Abstract][Full Text] [Related]
79. HLA class II haplotypes associated with pulmonary interstitial lesions of polymyositis/dermatomyositis in Japanese patients. Horiki T; Ichikawa Y; Moriuchi J; Hoshina Y; Yamada C; Wakabayashi T; Jackson K; Inoko H Tissue Antigens; 2002 Jan; 59(1):25-30. PubMed ID: 11972875 [TBL] [Abstract][Full Text] [Related]
80. Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey. Yoshida A; Li Y; Maroufy V; Kuwana M; Sazliyana Shaharir S; Makol A; Sen P; Lilleker JB; Agarwal V; Kadam E; Akawatcharangura Goo P; Day J; Milchert M; Chen YM; Dey D; Velikova T; Saha S; Edgar Gracia-Ramos A; Parodis I; Nikiphorou E; Tan AL; Nune A; Cavagna L; Toro Gutiérrez CE; Caballero-Uribe CV; Saavedra MA; Shinjo SK; Ziade N; El Kibbi L; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Rheumatol Adv Pract; 2024; 8(2):rkae028. PubMed ID: 38524696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]